Evidence map›Paper›PMID 26742633›Full record

ArticleJournal of translational medicine2016

Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue.

Florian T Unger, Nicole Lange, Jana Krüger, Carolyn Compton, Helen Moore, Lokesh Agrawal, Hartmut Juhl, Kerstin A David

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  5. Article
  6. Article
  7. The use of research biopsies in oncology trials: challenges and controversies.Journal of hospital management and health policy · 2019
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Societal challenges of precision medicine: Bringing order to chaos.European journal of cancer (Oxford, England : 1990) · 2017
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Florian T UngerIndivumed GmbH, Falkenried 88, 20251, Hamburg, Germany. unger@indivumed.com.
Nicole LangeIndivumed GmbH, Falkenried 88, 20251, Hamburg, Germany. lange@indivumed.com.
Jana KrügerIndivumed GmbH, Falkenried 88, 20251, Hamburg, Germany. krueger@indivumed.com.
Carolyn ComptonArizona State University, Phoenix, AZ, USA. Carolyn.Compton@asu.edu.
Helen MooreBiorepositories and Biospecimen Research Branch,National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. moorehe@mail.nih.gov.
Lokesh AgrawalBiorepositories and Biospecimen Research Branch,National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. lokesh.agrawal@nih.gov.
Hartmut JuhlIndivumed GmbH, Falkenried 88, 20251, Hamburg, Germany. juhl@indivumed.com.
Kerstin A DavidIndivumed GmbH, Falkenried 88, 20251, Hamburg, Germany. david@indivumed.com.
Dermatologikum Hamburg · DEArizona State University · USNational Cancer Institute · USNational Institutes of Health · US

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

backgroundClinical diagnostic research relies upon the collection of tissue samples, and for those samples to be representative of the in vivo situation. Tissue collection procedures, including post-operative ischemia, can impact the molecular profile of the tissue at the genetic and proteomic level. Understanding the influence of factors such as ischemia on tissue samples is imperative in order to develop both markers of tissue quality and ultimately accurate diagnostic tests.

methodsUsing NanoPro1000 technology, a rapid and highly sensitive immunoassay platform, the phosphorylation status of clinically relevant cancer-related biomarkers in response to ischemia was quantified in tissue samples from 20 patients with primary colorectal cancer. Tumor tissue and adjacent normal tissue samples were collected and subjected to cold ischemia prior to nanoproteomic analysis of AKT, ERK1/2, MEK1/2, and c-MET. Ischemia-induced relative changes in overall phosphorylation and phosphorylation of individual isoforms were calculated and statistical significance determined. Any differences in baseline levels of phosphorylation between tumor tissue and normal tissue were also analyzed.

resultsChanges in overall phosphorylation of the selected proteins in response to ischemia revealed minor variations in both normal and tumor tissue; however, significant changes were identified in the phosphorylation of individual isoforms. In normal tissue post-operative ischemia, phosphorylation was increased in two AKT isoforms, two ERK1/2 isoforms, and one MEK1/2 isoform and decreased in one MEK1/2 isoform and one c-MET isoform. Following ischemia in tumor tissue, one AKT isoform showed decreased phosphorylation and there was an overall increase in unphosphorylated ERK1/2, whereas an increase in the phosphorylation of two MEK1/2 isoforms was observed. There were no changes in c-MET phosphorylation in tumor tissue.

conclusionThis study provides insight into the influence of post-operative ischemia on tissue sample biology, which may inform the future development of markers of tissue quality and assist in the development of diagnostic tests.

Indexed as

Signal TransductionBiological AssayCell Line, TumorColorectal NeoplasmsErbB ReceptorsExtracellular Signal-Regulated MAP KinasesHumansIschemiaLuminescent MeasurementsMitogen-Activated Protein Kinase KinasesNanotechnologyPhosphorylationProtein IsoformsProteomicsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-metErbB ReceptorsExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinase KinasesProtein IsoformsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-met

Identifiers

PMID26742633
PMCPMC4705760
OpenAlexW2226367022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.